肝癌组织脂肪酸转位酶表达对手术切除治疗患者预后的影响

doi:10.3969/j.issn.1672-5069.2025.04.039

Journal of Practical Hepatology ›› 2025, Vol. 28 ›› Issue (4): 633-635.doi: 10.3969/j.issn.1672-5069.2025.04.039

Previous Articles Next Articles

Impact of cancerous tissue fatty acid translocase expression on prognosis of patients with hepatocellular carcinoma after hepatectomy

Feng Shengju, Zang Yichen, Tong Xiao, et al

Department of Pathology, Yulin Hospital, Affiliated to First Hospital, Xi'an Jiaotong University, Yulin 719000, Shaanxi Province, China

Received:2024-12-26 Online:2025-07-10 Published:2025-07-14

Abstract

Feng Shengju, Zang Yichen, Tong Xiao, et al. Impact of cancerous tissue fatty acid translocase expression on prognosis of patients with hepatocellular carcinoma after hepatectomy[J]. Journal of Practical Hepatology, 2025, 28(4): 633-635.

[1]	Wen Wen, Bai Jie, Li Yongguo. Impact of sarcopenic obesity on prognosis of patients with chronic liver diseases [J]. Journal of Practical Hepatology, 2025, 28(4): 481-484.
[2]	Zhang Meng, Dang Zhichun, Li Ting, et al. Platelet counts and coagulation functions in patients with primary liver cancer with underlying liver cirrhosis [J]. Journal of Practical Hepatology, 2025, 28(4): 577-580.
[3]	Peng He, Hao Jianling, Huang Jianye, et al. Targeted and immunotherapy plus TACE in the treatment of patient with primary liver cancer [J]. Journal of Practical Hepatology, 2025, 28(4): 593-596.
[4]	Wen Chaomei, Shi Haiyang. Diagnostic efficacy of ultrasound fine vascular imaging technology and intravenous contrast-enhanced ultrasonography in patients with focal liver lesions [J]. Journal of Practical Hepatology, 2025, 28(4): 609-612.
[5]	Wang Haoyu, Shi Danghui, Mao Yufeng. Influencing factors on postoperative stone residual and recurrence in patients with intrahepatic bile duct stones after partial hepatectomy and cholangioenterostomy [J]. Journal of Practical Hepatology, 2025, 28(4): 629-632.
[6]	Yang Yijin, Hong Han, Chen Bin, et al. FOLFOX in hepatic artery infusion chemotherapy with combination of lenvatinib and PD-1 inhibitors in treatment of patients with advanced primary liver cancer [J]. Journal of Practical Hepatology, 2025, 28(3): 426-429.
[7]	Dong Yanhong, Jiang Kun, Huang Hui, et al. MRI evaluation of intrahepatic residual lesions in patients with primary liver cancer after transcatheter arterial chemoembolization [J]. Journal of Practical Hepatology, 2025, 28(3): 434-437.
[8]	Sha Xinjie, Xia Xiaoliang. Diagnosis of benign and malignant liver tumors by magnetic resonance imaging enhancement scanning and diffusion-weighted imaging [J]. Journal of Practical Hepatology, 2025, 28(3): 438-441.
[9]	Huang Yan, Yang Zhiyong, Huang Qian, et al. Poor prognosis of patients with intrahepatic cholangiocarcinoma with high serum CEA, CA125, CYFRA21-1 and VEGF levels [J]. Journal of Practical Hepatology, 2025, 28(3): 442-445.
[10]	Song Rui, Yang Jiangong, Luo Liqin, et al. Serum alpha-fetoprotein levels in predicting prognosis of children with hepatoblastoma after hepatectomy [J]. Journal of Practical Hepatology, 2025, 28(3): 446-449.
[11]	Guo Jianhui, Zhou Yongbing, He Qin. Changes of serum sST2, TLR4, suPAR and Beclin1 levels in patients with HBV-related acute-on-chronic liver failure [J]. Journal of Practical Hepatology, 2025, 28(2): 230-233.
[12]	Li Shiwei, Li Jiaguo, Zhu Jing, et al. Serum ANGPTL2, sVAP-1 and HMGB1 level changes in patients with hepatitis B virus infection-related acute-on-chronic liver failure [J]. Journal of Practical Hepatology, 2025, 28(2): 234-237.
[13]	He Pei, Feng Lei, Cao Xianghong, et al. A Meta analysis of correlation of RNA m6A methylation to prognosis of patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2025, 28(2): 254-257.
[14]	Chen Siyu, Pang Yongping, Song Yunpeng, et al. Efficacy of TACE plus targeted immunotherapy in patients with advanced primary liver cancer [J]. Journal of Practical Hepatology, 2025, 28(2): 258-261.
[15]	Yan Junyao, Yin Guowen, Xu Qingyu, et al. Efficacy and safety of radiofrequency ablation plus atezolizumab in the treatment of patients with unresectable hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2025, 28(2): 262-265.

Impact of cancerous tissue fatty acid translocase expression on prognosis of patients with hepatocellular carcinoma after hepatectomy

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments